MinterEllison advised Aravax on the deal. Aravax secured a US$42 million Series B funding round and expanding its syndicate of investors. In December 2022, Aravax announced the opening...
You must be a Standard 1 Year member to access this content.
MinterEllison advised Ginkgo Bioworks in relation to its entry into a technical development agreement with Microba Life Sciences. Microba Life Sciences (ASX: MAP), a precision microbiome...
You must be a Standard 1 Year member to access this content.
Thomson Geer advised Microba Life Sciences on the matter. MinterEllison supported Ginkgo on its participation as a cornerstone investor. Gut health business Microba Life Sciences Ltd...
You must be a Standard 1 Year member to access this content.
MinterEllison has advised Ena Respiratory Pty Ltd, an investee company of the Medical Research Commercialisation Fund managed by Brandon Capital, on its demerger and transformative funding...
You must be a Standard 1 Year member to access this content.
